Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (19)

2023

  1. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety

    American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247

2022

  1. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  2. Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 668-676

  3. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2020

  1. Update of the hyperglycemia Gestational diagnosis during the COVID-19 pandemic

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 8, pp. 545-552

  2. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain

    Clinical Genetics, Vol. 95, Núm. 5, pp. 615-626

2017

  1. Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

    American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131

2016

  1. Mortalidad materna en España en el periodo 2010-2012: Resultados de la encuesta de la Sociedad Española de Ginecología (SEGO)

    Progresos de Obstetricia y Ginecologia, Vol. 59, Núm. 5, pp. 342-349

2014

  1. Extended regimens of combined hormonal contraception to reduce symptoms related to withdrawal bleeding and the hormone-free interval: A systematic review of randomised and observational studies

    European Journal of Contraception and Reproductive Health Care, Vol. 19, Núm. 5, pp. 321-339

2012

  1. Obstetric and perinatal outcome in women with twin pregnancy and gestational diabetes

    Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, Núm. 7, pp. 1084-1089

2010

  1. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: A case series

    Molecular Genetics and Metabolism, Vol. 99, Núm. 4, pp. 358-366

2009

  1. Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses

    Journal of Epidemiology and Community Health, Vol. 63, Núm. 1, pp. 64-68

2008

  1. Factors influencing pregnancy outcome in women with type 2 versus type 1 diabetes mellitus

    Acta Obstetricia et Gynecologica Scandinavica, Vol. 87, Núm. 1, pp. 43-49

2007

  1. Factors affecting women's selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study

    Contraception, Vol. 76, Núm. 2, pp. 77-83

2006

  1. Erratum: Evaluation of the effectiveness and clinical security of Menopur® in the ovarian stimulation in IVF-ICSI (Revista Iberoamericana de Fertilidad y Reproduccion Humana)

    Revista Iberoamericana de Fertilidad y Reproduccion Humana

  2. Evaluación de la efectividad y seguridad clínica de Menopur® en la estimulación de la ovulación en ciclos de FIV-ICSI

    Revista Iberoamericana de Fertilidad y Reproduccion Humana, Vol. 23, Núm. 4, pp. 245-255

2005

  1. Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia

    Diabetologia, Vol. 48, Núm. 9, pp. 1736-1742

  2. Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain

    Diabetologia, Vol. 48, Núm. 6, pp. 1135-1141